当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 现金流量表

复星医药

(600196)

  

流通市值:482.59亿  总市值:608.32亿
流通股本:21.18亿   总股本:26.70亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金30,850,945,235.6820,516,123,126.5510,036,720,780.242,051,276,895.9
  收到的税费返还267,121,236.18194,893,862.38120,411,573.95383,454,967.68
  收到其他与经营活动有关的现金1,539,814,117.781,258,632,548.5947,760,302.74880,686,797.76
  经营活动现金流入小计32,657,880,589.6421,969,649,537.4311,104,892,656.8943,315,418,661.34
  购买商品、接受劳务支付的现金10,365,480,198.276,783,016,303.123,339,525,252.6214,670,081,647.98
  支付给职工以及为职工支付的现金9,064,786,805.056,239,182,119.283,197,848,208.0811,245,753,461.99
  支付的各项税费2,001,691,097.551,419,992,409686,177,071.612,674,701,462.59
  支付其他与经营活动有关的现金7,798,820,359.935,103,506,291.352,732,744,336.769,511,655,210.43
  经营活动现金流出小计29,230,778,460.819,545,697,122.759,956,294,869.0738,102,191,782.99
  经营活动产生的现金流量净额3,427,102,128.842,423,952,414.681,148,597,787.825,213,226,878.35
二、投资活动产生的现金流量:
  收回投资收到的现金910,761,411.3500,064,407.2347,569,016.662,450,861,304.17
  取得投资收益收到的现金215,883,869.08180,265,477.55122,511,415.01792,055,953.78
  处置固定资产、无形资产和其他长期资产收回的现金净额54,656,114.3752,312,018.5543,817,389.5981,902,433.52
  处置子公司及其他营业单位收到的现金净额100,201,800.24101,778,535.865,841,904.03230,623,552
  收到的其他与投资活动有关的现金249,633,071.1272,872,511.1910,550,546.86166,815,422.57
  投资活动现金流入小计1,531,136,266.11907,292,950.29590,290,272.153,722,258,666.04
  购建固定资产、无形资产和其他长期资产支付的现金4,266,574,045.042,428,860,345.661,091,365,638.924,448,451,634.91
  投资支付的现金1,736,899,943.371,450,737,987.65671,162,856.2937,720,065.36
  取得子公司及其他营业单位支付的现金324,166,869.1307,813,252.43297,095,544.2533,976,446.7
  支付其他与投资活动有关的现金762,542,195.041,147,979,675.1259,950,736.18447,876,807.8
  投资活动现金流出小计7,090,183,052.555,335,391,260.842,319,574,775.555,868,024,954.77
  投资活动产生的现金流量净额-5,559,046,786.44-4,428,098,310.55-1,729,284,503.4-2,145,766,288.73
三、筹资活动产生的现金流量:
  吸收投资收到的现金197,048,347.01135,137,918.1925,032,000218,263,053.21
  其中:子公司吸收少数股东投资收到的现金197,048,347.01135,137,918.1925,032,000218,263,053.21
  取得借款收到的现金24,403,973,463.1913,103,690,508.147,821,034,931.6336,258,205,827.74
  收到其他与筹资活动有关的现金2,455,019,083.03690,410,284.88107,291,170.84857,550,499.2
  筹资活动现金流入小计27,056,040,893.2313,929,238,711.217,953,358,102.4737,334,019,380.15
  偿还债务支付的现金21,093,000,252.6910,291,818,526.936,317,691,422.1136,493,980,610.54
  分配股利、利润或偿付利息支付的现金2,269,952,749.06659,524,027.47250,088,995.612,315,321,975.78
  其中:子公司支付给少数股东的股利、利润305,119,877.81169,124,170.947,727,047.95370,679,415.07
  支付其他与筹资活动有关的现金709,740,578.83301,892,144.84107,382,486.231,768,806,300.98
  筹资活动现金流出小计24,072,693,580.5811,253,234,699.246,675,162,903.9540,578,108,887.3
  筹资活动产生的现金流量净额2,983,347,312.652,676,004,011.971,278,195,198.52-3,244,089,507.15
四、汇率变动对现金及现金等价物的影响-319,036,554.6-222,600,992.35-158,570,564.25-176,810,748.88
五、现金及现金等价物净增加额532,366,100.45449,257,123.75538,937,918.69-353,439,666.41
  加:期初现金及现金等价物余额9,038,010,120.79,038,010,120.79,038,010,120.79,391,449,787.11
  期末现金及现金等价物余额9,570,376,221.159,487,267,244.459,576,948,039.399,038,010,120.7
补充资料:
  净利润-2,148,928,430.32-4,247,929,628.38
  资产减值准备-14,942,862.94-150,063,042.97
  固定资产和投资性房地产折旧-833,695,167.35-1,782,627,838.46
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-833,695,167.35-1,782,627,838.46
  无形资产摊销-678,791,505.45-1,362,330,066.18
  长期待摊费用摊销-120,485,813.61-211,406,402.92
  处置固定资产、无形资产和其他长期资产的损失--195,231.96--69,350,406.88
  固定资产报废损失-1,703,734.07-9,848,475.82
  公允价值变动损失--273,651,844.51-322,268,457.29
  财务费用-529,998,254.39-1,109,132,867.54
  投资损失--1,493,305,373.4--3,763,778,024.02
  递延所得税-64,753,657.65--326,000,447.95
  其中:递延所得税资产减少--29,558,937.83--253,876,291.87
    递延所得税负债增加-94,312,595.48--72,124,156.08
  存货的减少-443,646,870.02-1,236,227,214.47
  经营性应收项目的减少-319,646,036.81--1,011,067,423.03
  经营性应付项目的增加--1,505,908,352.79--748,906,006.61
  不涉及现金收支的投资和筹资活动金额其他项目-157,105,861.54-1,066,676,562.95
  现金的期末余额-9,487,267,244.45-9,038,010,120.7
  减:现金的期初余额-9,038,010,120.7-9,391,449,787.11
  现金及现金等价物的净增加额-449,257,123.75--353,439,666.41
公告日期2026-10-282026-08-262026-04-292026-03-25
审计意见(境内)标准无保留意见
TOP↑